• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Hyderabad, Sept. 5

Dr Reddy’s Laboratories Ltd has launched Ebernet (Eberconazole 1% cream) targeting Rs 100 crore topical anti-fungal market. Ebernet, which marks the Hyderabad-based company’s foray into anti-fungal segment, is indicated in the treatment of superficial fungal infections, according to a release. The product is available in 10 gm pack. Ebernet is a brand licensed from the original innovator company, Salvat Laboratories of Spain.

— Our Bureau

More Stories on : Announcements | New Products & Services | Pharmaceuticals | Dr. Reddy's Laboratories Ltd

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Dr Reddy’s anti-fungal foray

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line